Tristel plc (LSE:TSTL) reported a 10% increase in annual revenue to £51.1 million, alongside a 15% rise in adjusted pre-tax profit to £11.7 million, supported by higher sales across its principal markets, including an increased contribution from the United States.
The AIM-listed infection prevention specialist maintained a gross profit margin of 82% during the financial year and increased its full-year dividend by 5%.
Tristel ended the reporting period with £16.0 million in cash and short-term investments and no outstanding debt.
The company also completed its transition to in-house wipe manufacturing, introduced new cleaning and digital compliance products, and appointed Chris Lee as chief executive officer.
Revenue Growth Across UK, European and US Markets
Tristel reported increased sales in the United Kingdom and Europe, alongside a larger revenue contribution from its US operations.
The company attributed part of its US growth to increased adoption of its Tristel ULT and Tristel OPH products, which form part of its medical device decontamination portfolio.
Tristel also highlighted the expansion of US clinical guidelines supporting the use of chlorine dioxide technology, the chemical basis of its disinfectant products.
The group develops and supplies infection prevention products for healthcare settings, including solutions used in the manual decontamination of medical devices and sporicidal surface disinfection.
Its operations extend across more than 40 countries through a network of 16 subsidiaries and distribution arrangements.
The increased contribution from the United States forms part of Tristel’s ongoing international expansion strategy.
Adjusted Pre-Tax Profit Increases 15% to £11.7 Million
Tristel reported adjusted pre-tax profit of £11.7 million, representing a 15% increase from the previous financial year.
Revenue rose by 10% to £51.1 million, while the gross profit margin remained at 82%.
The company maintained its focus on profitability alongside revenue expansion, supported by its established disinfectant product portfolio and international operations.
Tristel has a stated objective of achieving double-digit annual revenue growth while maintaining an adjusted EBITDA margin of at least 25%.
The company did not provide an adjusted EBITDA figure for the reporting period in the supplied update.
In-House Wipe Manufacturing Transition Completed
During the financial year, Tristel completed its transition to manufacturing wipes internally.
The move represents a change in the group’s production arrangements, bringing wipe manufacturing operations within the business rather than relying on external production.
The company also introduced VISICLEAN, a cleaning technology developed as part of its infection prevention product offering.
These developments form part of Tristel’s ongoing investment in manufacturing capabilities and product development.
The supplied update does not quantify the financial contribution from VISICLEAN or the impact of the manufacturing transition on operating costs.
3T Pro Introduced as First Paid Digital Compliance Platform
Tristel expanded its digital product offering with the launch of 3T Pro, its first paid digital compliance platform.
The product is intended to support healthcare customers with compliance-related processes associated with infection prevention and decontamination activities.
The launch introduces a paid digital service alongside Tristel’s existing disinfectant and cleaning product portfolio.
The company has identified digital services as an area for future development, with the aim of expanding its revenue sources beyond physical infection prevention products.
No revenue contribution or subscriber figures for 3T Pro were disclosed in the supplied update.
Chris Lee Appointed Chief Executive Officer
Tristel appointed Chris Lee as chief executive officer during the period.
The company identified international expansion and the development of digital revenue as priorities under the new leadership.
Lee brings previous industry experience to the role and will oversee the group’s continued development across its established and emerging markets.
Tristel operates from its headquarters near Cambridge and employs approximately 280 people across its international business.
Full-Year Dividend Increased by 5%
Tristel increased its full-year dividend by 5%, continuing its policy of progressive shareholder distributions.
The company ended the financial year with £16.0 million in cash and short-term investments and no debt.
Its financial position reflects the group’s reported profitability and cash holdings at the end of the period.
The company continues to pursue its stated financial objectives of double-digit annual revenue growth and an adjusted EBITDA margin of at least 25%.
Tristel’s operational priorities include expanding its US business, developing its digital compliance offering and integrating its in-house manufacturing activities.
The company enters its next financial year following revenue growth across its principal markets, the introduction of additional products and changes to its manufacturing and management structure.
Leave a Reply